di-tert-butyl peroxide has been researched along with sorafenib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, Z; Chiu, DK; Koh, HY; Lai, RK; Law, CT; Lin, SH; Ng, IO; Tse, AP; Wong, CC; Wong, CM; Xu, IM | 1 |
1 other study(ies) available for di-tert-butyl peroxide and sorafenib
Article | Year |
---|---|
Transketolase counteracts oxidative stress to drive cancer development.
Topics: Animals; Base Sequence; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cell Proliferation; Female; Gene Knockdown Techniques; Glucose; Glutathione; Glycolysis; Humans; Liver Neoplasms; Male; Metabolome; Mice, Nude; Molecular Sequence Data; Niacinamide; Oxidative Stress; Pentose Phosphate Pathway; Peroxides; Phenylurea Compounds; Reactive Oxygen Species; RNA, Messenger; Sorafenib; Transketolase; Up-Regulation | 2016 |